MedTrace Logo

Effectiveness of Sitagliptin in Glycemic Control in Real World

NCT01316835 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1120

Last updated 2011-03-16

No results posted yet for this study

Summary

This study will evaluate whether the addition of sitagliptin treatment provides additional decrease in HbA1C levels and increase in goal attainment in patients with inadequate glycemic control on their current oral anti-glycemic therapy in real world practice.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Ching-Jung Hsieh, MD · Chang Gung Memorial Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01316835 on ClinicalTrials.gov